Evidence map›Paper›PMID 41686851›Full record

ArticlePLOS global public health2026

Temporal patterns and risk factors of diarrheal comorbidity among children aged < 5 years in rural western Kenya: Evidence from three consecutive enteric studies, 2008-2024.

Billy Ogwel, Bryan O Nyawanda, Brian O Onyando, Alex O Awuor, Caleb Okonji, Raphael O Anyango, Caren Oreso, Catherine Sonye, John B Ochieng, Stephen Munga and 5 more

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Billy OgwelCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.ORCID https://orcid.org/0000-0002-9097-2713
Bryan O NyawandaCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.
Brian O OnyandoCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.ORCID https://orcid.org/0009-0009-8953-5215
Alex O AwuorCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.ORCID https://orcid.org/0009-0003-9138-7748
Caleb OkonjiCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.
Raphael O AnyangoCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.
Caren OresoCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.ORCID https://orcid.org/0009-0005-5043-5728
Catherine SonyeCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.
John B OchiengCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.ORCID https://orcid.org/0000-0002-5301-4559
Stephen MungaCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.
Dilruba NasrinDepartment of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Karen L KotloffDepartment of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Patricia B PavlinacDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.
Richard OmoreCenter for Global Health Research, Kenya Medical Research Institute- (KEMRI-CGHR), Kisumu, Kenya.ORCID https://orcid.org/0000-0003-3702-3030
Elizabeth T Rogawski McQuadeDepartment of Epidemiology, Emory University, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0002-4942-3747

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sub-Saharan Africa bears the highest burden of diarrhea, often complicated by comorbidities that delay diagnosis, hinder treatment, and worsen outcomes. As the epidemiology of diarrheal disease evolves, understanding comorbidity patterns is critical for effective public health responses. We examined the temporal patterns and risk factors of diarrheal comorbidity in Kenyan children aged < 5. We conducted secondary pooled analysis with a retrospective cohort design leveraging data from the Global Enteric Multicenter Study (GEMS, 2008-2012), the Vaccine Impact on Diarrhea in Africa (VIDA, 2015-2018), the Enteric for Global Health (EFGH) Shigella surveillance study (2022-2024). The outcome was comorbidity count, defined by Integrated Management of Childhood Illnesses case definitions and clinician diagnoses of ten conditions: malaria, bacterial infection, pneumonia, severe acute malnutrition (SAM), meningitis, acute febrile illness (AFI), respiratory Illness (non-pneumonia), anemia, stunting and wasting. Temporal trends were assessed using descriptive statistics and the Cochran-Armitage trend test. Risk factors were identified using generalized estimating equations with a Poisson distribution, adjusting for clustering. We analyzed data from 4,148 children with moderate-to-severe diarrhea; 90.3% had ≥ one comorbidity, with a declining trend across studies: GEMS (92.9%), VIDA (89.3%), and EFGH (86.6%). Pneumonia (49.5%), malaria (48.3%), and stunting (24.7%) were most common comorbidities. The proportion of children with only one comorbidity increased (28.9% [2008] to 49.7% [2024]), while multiple comorbidities declined. Traditional comorbidities (malaria, pneumonia, wasting, SAM) significantly decreased, while AFI, anemia, and non-pneumonia respiratory illness increased. Multivariable analysis identified older age, lower caregiver education, dehydration, vomiting, 3-month lagged rainfall and temperature, and high respiratory rate as drivers of higher comorbidity counts, while female sex was associated with fewer comorbidities. Despite the high prevalence, we observed a 20-23% decline in comorbidity burden and a fundamental shift in disease profiles. Our findings support the need for a shift from single-disease control to integrated disease management.

Identifiers

PMID41686851
PMCPMC12904429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.